NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitorsNF1-depleted ER+乳腺癌对CDK4/6抑制剂的敏感性存在差异。Science Translational MedicineIF14.62025-08-270PRE
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast CancerMOLECULAR CANCER THERAPEUTICSIF5.52024-05-232OAAI
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast CancerCANCER RESEARCHIF16.62023-04-185OAAI
Targeting coactivators to inhibit ESR1 fusion-driven breast cancer growthCANCER RESEARCHIF16.62023-04-141PRE
Targeting kinome reprogramming in ESR1 fusion-driven breast cancerCANCER RESEARCHIF16.62023-04-040PRE
Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer's DiseaseFRONTIERS IN CELLULAR NEUROSCIENCEIF42022-02-075OAAI
A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging (vol 52, pg 731, 2016)JOURNAL OF ALZHEIMERS DISEASEIF3.12016-10-040OAAI
A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance ImagingJOURNAL OF ALZHEIMERS DISEASEIF3.12016-05-1037OAAI
Formaldehyde scavengers function as novel antigen retrieval agentsSCIENTIFIC REPORTSIF3.92015-11-2710OAAI